Loading clinical trials...

A Latino MSM Focused Pre-Exposure Prophylaxis Uptake Intervention | Clinical Trials | Clareo Health

UNKNOWNNA

A Latino MSM Focused Pre-Exposure Prophylaxis Uptake Intervention

Evaluating the Feasibility and Acceptability of a Latino MSM Focused PrEP Uptake Intervention

NCT05434390•University of California, Los Angeles

Summary

The clinical study will evaluate the feasibility and acceptability of a culturally tailored behavioral intervention to improve uptake of pre-exposure prophylaxis for HIV prevention among at-risk Latino men who have sex with men.

Detailed Description

The clinical study will evaluate the feasibility and acceptability of a brief small group and peer navigation behavioral intervention to improve uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among at-risk Latino men who have sex with men. The brief intervention consists of 4 small group sessions with concurrent peer navigation and counseling. Study participants will be randomized to either an intervention or control condition. Participants in the control condition will receive usual care for PrEP promotion (i.e., referral to PrEP services). The study will determine the feasibility and acceptability of the intervention among Latino men who have sex with men and assess the preliminary impact of the intervention compared to control condition in facilitating PrEP uptake.

Eligibility

Age

18 - No limit years

Sex

MALE

Healthy Volunteers

Yes

Inclusion Criteria

•18 years of age or older
•assigned male at birth
•Identifies as Latino/Hispanic origin
•HIV-negative or HIV status unknown
•Man who has had sex with other men in the past 24 months
•Not currently using PrEP for HIV prevention

Exclusion Criteria

•Male under 18 years of age
•Not identifying as being of Latino/Hispanic origin
•Man who has not had sex with other men in the past 24 months
•Identifies as cisgender or transgender Female/woman
•Assigned female at birth

Locations (1)

Bienestar Human Services

Los Angeles, California, United States

Key Dates

Start Date

October 3, 2022

Primary Completion Date

December 1, 2023

Completion Date

April 1, 2024

Last Updated

November 8, 2022

Enrollment

ESTIMATED participants

Conditions

HIV

Interventions

Estoy PrEParado/ I am PrEPared intervention

BEHAVIORAL

Usual Care

BEHAVIORAL

Contacts

Ronald A Broooks, PhD

CONTACT

310-794-0773 rabrooks@mednet.ucla.edu

Omar Nieto, BA

CONTACT

310-794-0229 onieto@mednet.ucla.edu

Thinking and Memory Problems in People With HIV

NCT01875588

HIV Positive

View study

RECRUITINGPHASE2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

NCT04929028

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 8, 2022Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Latino MSM Focused Pre-Exposure Prophylaxis Uptake Intervention

Inclusion Criteria

Exclusion Criteria

Thinking and Memory Problems in People With HIV

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

The LD Lync Study - Natural History Study of Lipodystrophy Syndromes

Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption